Scoggin Management’s TG Therapeutics TGTX Stock Holding History

Scoggin Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-88,351	Closed	-$445K	–	113
2013 Q3	$445K	Buy	+88,351	New	+$540K	0.04%	85

Other funds holding TGTX

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Scoggin Management's TGTX Position: Q4 2013 in Review

Scoggin Management sold out of TG Therapeutics (TGTX) in Q4 2013, closing a stake of 88,351 shares — an estimated $445K sold.

Scoggin Management first reported a position in TGTX in Q3 2013 and held it in 1 quarter. The position peaked at $445K in Q3 2013. 45 funds tracked by Wall St. Rank hold TGTX as of Q4 2013.

Scoggin Management reported no remaining TG Therapeutics position as of Q4 2013 after selling out during the quarter.
Scoggin Management sold 88,351 TG Therapeutics shares in Q4 2013, an estimated $445K.
Scoggin Management first reported a position in TG Therapeutics in Q3 2013 and held it in 1 quarter.
Scoggin Management's TG Therapeutics position peaked at $445K in Q3 2013.
45 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2013.

Based on Scoggin Management's 13F filing for Q4 2013, filed 14 Feb 2014.